Questions a plan sponsor actually asks.
What is Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine used for?
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.
Is there a generic for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine?
No. Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine is brand-only with no generic equivalents currently in market.
How much does my plan pay for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine?
Across 329 Part D plans, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine averages $0.475/unit (NADAC). Lowest available: $0.239/unit. Highest in distribution: $0.619/unit.
Is Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine on the FDA shortage list?
No. Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine is not currently on the FDA Drug Shortage Database.
3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.